Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Computational Biology Market to Hit $20.5 Billion, Globally, by 2030 at 17.6% CAGR: Coherent Market Insights (CMI)

Published

on

Burlingame, July 24, 2023 (GLOBE NEWSWIRE) — Coherent Market Insights published a report, titled, “Computational Biology Market, By Type (Cellular and Biological Simulation (Computational Genomics, Computational Proteomics, Pharmacogenomics, and Others (Transcriptomics/Metabolomic)), Disease Modeling and Simulation Applications (Drug Discovery, Drug Development)), By Tools (Content/Database, Analysis Software and Services, and IT Infrastructure (Hardware))”: Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030”. According to Coherent Market Insights, the global computational biology market is estimated to be valued at US$ 6.6 billion in 2023 and is expected to exhibit a CAGR of 17.6% during the forecast period (2023-2030).

Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/3915

Analysts’ Views on the Global Computational Biology Market:

The increasing prevalence of chronic diseases, increasing research and development in the field of computational biology, and collaboration between key markets players are expected to drive the global computational biology market growth. For instance, according to an article published by the Department of Biotechnology, a Government of India office of Ministry of Science and Technology on February 17, 2022, the need of computational have increased due to increase in genome sequencing projects. Major activities such as MANAV: Human Atlas Initiative, DAICENTER Program, DBT Apex BTIC have been established by government of India. Department of Biotechnology has established Bioinformatics and Computational Biology Centers, and started applications of artificial intelligence, machine learning, and other high-throughput data related informatics in various sectors of life sciences. This has been planned with a focused attempt to engage best expertise in development and advancement of computational tools and technologies from various institutions. Such government initiatives can drive growth of global computational biology market.

Global Computational Biology MarketDriver

Increasing launch of computational biology technologies

The launch of newer computational biology technologies is expected to drive the global computational biology market growth during the forecast period. For instance, on May 24, 2021, the World Health Organization (WHO) signed a Memorandum of Understanding (MoU) with Swiss Confederation to launch the first WHO BioHub Facility as a part of WHO BioHub System, this facility will serve as a center for the safe receipt, sequencing, storage and preparation of biological materials. This BioHub facility will allow pathogens information sharing between laboratories and facilitate “analysis and preparedness” against them.

Computational Biology Market Report Coverage

Report Coverage Details
Base Year: 2022   Market Size in 2023: US$ 6.6 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 to 2030
Forecast Period 2023 to 2030 CAGR: 17.6%   2030 Value Projection: US$ 20.5 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Cellular & Biological Simulation(Computational Genomics, Computational Proteomics, Pharmacogenomics, Others (Transcriptomics/Metabolomic)) Disease Modeling and Simulation Applications(Drug Discovery, Drug Development)
  • By Tools: Content/Database, Analysis Software & Services, IT Infrastructure (Hardware)
Companies covered: Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia  Pharma SAS, Schrodinger, and Simulation Plus, Inc.
Growth Drivers:
  • Increasing clinical trial activities using computational designs
  • Increasing launches of new technologies in computational biology
Restraints & Challenges:
  • Lack of standardization of life science data
  • Issues of data storage

Global Computational Biology Market– Restraint

Lack of skilled professionals

The lack of skilled professionals in the field of computational biology is one of the major restraints for the global computational biology market. For instance, according to an article published on December 9, 2021, Plos Computational Biology, with the large amount of data in biology and the increasing demand for data analysis skills, bioinformatics has become an essential discipline for many areas of biology, including genetics, genomics, proteomics, and systems biology. As a result, there is a high demand for bioinformatics professionals. Bioinformatics is an interdisciplinary field that requires individuals to have a strong background in both biology and computer science, making it challenging to find individuals with the necessary skills. Secondly, the rapid growth of the field has outpaced the development of training programs and courses, leading to a lack of formal education and training opportunities for individuals. Thirdly, the field is highly competitive, and many individuals with bioinformatics skills are drawn to lucrative positions in the tech industry, which results in reduced skilled professionals.

In order to counterbalance this restraint, newer courses should be introduced and funding opportunities should be provided for bioinformatics research which will encourage the development of interdisciplinary collaborations and training programs.

Global Computational Biology Market– Opportunity

Growth strategies like partnerships by key market players

Increasing growth strategies like partnerships for computational biology by key market players is expected to offer growth opportunities to the market. For instance, on January 6, 2022, Amgen Inc., a U.S.-based multinational biopharmaceutical company, announced a research collaboration agreement with Generate Biomedicines, a U.S.-based biotechnology company, to discover and create protein therapeutics for five clinical targets across several therapeutic areas and multiple modalities. As part of the research collaboration, Amgen will pay US$ 50 million in upfront funding for the initial five programs with a potential transaction value of US$ 1.9 billion plus future royalties, and will have the option to nominate up to five additional programs, at additional costs. For each program, Amgen will pay up to US$ 370 million in future milestones and royalties up to low double digits. Amgen will also participate in a future financing round for Generate Biomedicines.

Buy Now this Premium Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3915

Global Computational Biology Market Cross Sectional Analysis:

Among the tools segment, the analysis software and services segment was dominant during the forecast period in Europe due to increasing collaborations by key market players for computational technologies. For instance, on September 13, 2021, Uphill, a Portuguese-based digital health startup, developed software to guide clinical decisions. This software has raised US$ 3.8 million in a seed round to scale up the software. The seed round was led by Brighteye Ventures and MSM.

Global Computational Biology Market Segmentation:

The global computational biology market report is segmented into type, tools, and region.

Based on type, the global computational biology market is segmented into cellular and biological simulation and disease modeling and simulation applications. Out of which, the cellular and biological simulation segment is expected to dominate the market due to increasing research and development activities.

Based on tools, the global computational biology market is segmented into content/database, analysis software and services, IT infrastructure (hardware). Among these, the analysis software and services segment is expected to dominate the market over the forecast period due to the increasing usage of these software in computational biology.

Based on region, the global computational biology market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Among these, North America is expected to dominate the market over the forecast period due to increasing product launches in this segment.

Among all segmentation, the type segment has the highest potential due to increasing launches of products by the key market players. For instance, according to an article published by a journal, Theoretical and Computational Chemistry on January 18, 2023, computational microscopes can be employed to model an entire cell, the minimal cell, JCVI-syn3A, at full complexity. This approach interrogates the cell’s spatio-temporal evolution with molecular dynamics simulations, an approach that can be extended to other cell types in the near future.

Global Computational Biology Market: Key Developments

The strategies by key market players like collaborations is expected to drive the market growth. For instance, on October 27, 2021, Lantern Pharma, a U.S.-based clinical stage biotechnology company announced a collaboration with Code Ocean Inc., a U.S.-based computational research platform for artificial intelligence driven computational research on oncology-focused drug discovery and development using its proprietary RADR artificial intelligence platform to transform the cost, pace, and timeline of oncology drug discovery and development. By leveraging Code Ocean’s Compute Capsule technology, the strategic approach is expected to further power Lantern Pharma’s RADR platform for faster, more collaborative discoveries from billions of RADR data points, as well as data and insights from Lantern Pharma’s network of collaborators.

Strategies like acquisition by key market players can drive the growth of the market over the forecast period. For instance, on July 25, 2022, Cadence Design systems Inc., a U.S.-based computational software company announced that it entered into a definitive agreement to acquire OpenEye Scientific Software, Inc., a U.S.-based provider of computational molecular modeling and simulation software being widely and increasingly used by pharmaceutical and biotechnology companies for drug discovery. The addition of OpenEye’s technologies and team with its scientific expertise accelerates Cadence’s Intelligent System Design growth by expanding its Total Addressable Market (TAM).

Key Market Takeaways:

The global computational biology market is expected to exhibit a CAGR of 17.6% during the forecast period due to increasing launches of new products

Among type, the cellular and biological simulation segment is dominant due to the products launched by the key market players. For instance, on January 23, 2023, QIAGEN N.V., a Europe-based molecular diagnostic company, launched an ultra-fast NGS analysis to process the whole genome on 25 minutes for US$ 1 in cloud computing cost. The new product QIAGEN CLC Genomics Workbench Premium removes the data-analysis bottleneck of Next-generation Sequencing (NGS) by adding game-changing analysis speed to analyze and interpret Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), and large panel sequencing data.

Competitive Landscape:

The key players operating in the global computational biology market are Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.

Request Customization of this Report @ https://www.coherentmarketinsights.com/insight/request-customization/3915

Detailed Segmentation:
Global Computational Biology Market, By Type:

  • Cellular and Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
  • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development

Global Computational Biology Market, By Tools:

  • Content/Database
  • Analysis Software and Services
  • IT Infrastructure (Hardware)

Global Computational Biology Market, By Region:

  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • By Country
      • North Africa
      • Central Africa
      • South Africa

Related Market Intelligence Reports:

Real-world Data (RWD) Market, By Source (Electronic health records (EHRs), Claims data, Pharmacy data, Patient-reported outcomes (PROs), Disease registries, Other sources), By Application (Drug development and approvals, Market access and reimbursement/coverage decisions, Post-market surveillance, Clinical research, Other applications), By End User (Pharmaceutical and medical device companies, Healthcare payers, Healthcare providers, Government agencies, Other end users), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030

Assistive Technology Market, By Product Type (Mobility Devices, Hearing Aids, Vision and Reading Aids, Communication Devices, Daily Living Aids, Prosthetics and Orthotics, Assistive Software and Apps, Others (cognitive aids, sensory stimulation devices, environmental control systems)), By Disability Type (Mobility Impairment, Hearing Impairment, Visual Impairment, Speech and Language Impairment, Cognitive Impairment, Others (autism, developmental disorders, multiple disabilities)), By Age Group (Children, Adults, Elderly), By Distribution Channel (Retail Stores, Online Retail, Healthcare Institutions, Others (specialty stores, assistive technology centers)), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Follow Us: LinkedInTwitter


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Cognitive Security Market Projected to Reach $134.26 billion by 2030 – Exclusive Report by 360iResearch

Published

on

cognitive-security-market-projected-to-reach-$134.26-billion-by-2030-–-exclusive-report-by-360iresearch

PUNE, India, April 26, 2024 /PRNewswire/ — The report titled “Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical – Global Forecast 2024-2030” is now available on 360iResearch.com’s offering, presents an analysis indicating that the market projected to grow from a size of $19.50 billion in 2023 to reach $134.26 billion by 2030, at a CAGR of 31.73% over the forecast period.

“The Global Rise of Cognitive Solutions Against Cyber Threats”
The field of cognitive security, leveraging the latest in artificial intelligence (AI), machine learning (ML), and data analytics, is reshaping the way physical and digital assets are protected from cyber threats. This innovative approach learns from user interactions with systems and data, enabling real-time threat detection and a more dynamic defense strategy. Across industries, including finance, healthcare, retail, and government, cognitive security applications, such as fraud detection and cyber defense, are becoming vital in navigating the complex threat landscape. Challenges in integrating with older systems and opportunities include advancements in AI and technology. Globally, the cognitive security market is witnessing rapid growth, driven by high American demand and significant investments in the Asia-Pacific region. In Europe, stringent regulations such as GDPR drive the demand for compliant solutions, while in the Middle East and Africa, the expanding telecom sector highlights the need for robust cybersecurity measures. This global momentum highlights the critical role of cognitive security in an interconnected world, ensuring businesses and governments can overcome cyber threats.
Download Sample Report @ https://www.360iresearch.com/library/intelligence/cognitive-security
“The Essential Role of Cognitive Security in Today’s Digital Age”
As digital transformation reshapes industries, the surge in data generation and intricate data management challenges have outpaced traditional cyber defense mechanisms. Cognitive security adept at processing and analyzing vast arrays of data in real-time, uncovering patterns and anomalies indicative of cybersecurity threats. This advanced approach enables proactive threat detection and swift response measures, significantly mitigating the risks of data breaches and cyber incidents. Cognitive security solutions adeptly handle diverse data types at unparalleled speeds, offering insights typically elusive to manual analysis by harnessing the power of automation. These systems excel at unveiling sophisticated attacks, skillfully hidden within normal network activities, and continuously evolve through machine learning. This perceptual adaptation is vital in a landscape where cyber threats rapidly transform, and digitalization ushers in new vulnerabilities. Cognitive security is a staunch supporter for organizations, ensuring their security policies remain in lockstep with the ever-evolving cyber threat environment and regulatory demands, thus fortifying digital defenses in an increasingly connected world.
“Enhancing Digital Security through Advanced Cognitive Technologies”
In an era where cyber threats are constantly evolving, the importance of robust digital security mechanisms cannot be overstated. The approach encompasses a suite of essential services that ensure the effective operation and continuous improvement of cognitive security systems. These include the meticulous deployment and integration of these systems into existing organizational structures, ensuring they work seamlessly with current technologies and protocols. Ongoing support and maintenance to keep these systems at the forefront of cyber defense, alongside training and consulting to empower staff with the knowledge and skills needed to optimize these advanced security solutions. Cutting-edge technologies include biometric recognition, digital signature authentication, real-time security analytics, and a unified platform managing security logs and data. Each component is vital role in creating a secure digital environment that identifies threats and enables swift, informed responses to protect organizational assets and data.
Request Analyst Support @ https://www.360iresearch.com/library/intelligence/cognitive-security
“International Business Machines Corporation at the Forefront of Cognitive Security Market with a Strong 8.44% Market Share”
The key players in the Cognitive Security Market include Google LLC by Alphabet Inc., Microsoft Corporation, Fortinet, Inc., International Business Machines Corporation, Cisco Systems, Inc., and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.
“Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Cognitive Security Market”
We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Cognitive Security Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it’s a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Cognitive Security Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi @ https://app.360iresearch.com/library/intelligence/cognitive-security
“Dive into the Cognitive Security Market Landscape: Explore 192 Pages of Insights, 760 Tables, and 28 Figures”
PrefaceResearch MethodologyExecutive SummaryMarket OverviewMarket InsightsCognitive Security Market, by ComponentCognitive Security Market, by Security TypeCognitive Security Market, by ApplicationCognitive Security Market, by Deployment ModeCognitive Security Market, by Enterprise TypeCognitive Security Market, by VerticalAmericas Cognitive Security MarketAsia-Pacific Cognitive Security MarketEurope, Middle East & Africa Cognitive Security MarketCompetitive LandscapeCompetitive PortfolioInquire Before Buying @ https://www.360iresearch.com/library/intelligence/cognitive-security
Related Reports:
Cognitive Radio Market – Global Forecast 2024-2030Cognitive Electronic Warfare System Market – Global Forecast 2024-2030Cognitive Data Management Market – Global Forecast 2024-2030About 360iResearch
Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset — our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
Contact 360iResearchMr. Ketan Rohom360iResearch Private Limited,Office No. 519, Nyati Empress,Opposite Phoenix Market City,Vimannagar, Pune, Maharashtra,India – 411014.Email: [email protected]: +1-530-264-8485India: +91-922-607-7550
To learn more, visit 360iresearch.com or follow us on LinkedIn, Twitter, and Facebook.
Logo: https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/cognitive-security-market-projected-to-reach-134-26-billion-by-2030—exclusive-report-by-360iresearch-302126101.html

Continue Reading

Artificial Intelligence

IBM, Government of Canada, Government of Quebec Sign Agreements to Strengthen Canada’s Semiconductor Industry

Published

on

ibm,-government-of-canada,-government-of-quebec-sign-agreements-to-strengthen-canada’s-semiconductor-industry

Up to $187M CAD to be invested to progress expansion of chip packaging capacity and capabilities and to strengthen R&D at IBM Canada’s Bromont plant
BROMONT, QC, April 26, 2024 /PRNewswire/ — IBM (NYSE: IBM), the Government of Canada, and the Government of Quebec today announced agreements that will strengthen Canada’s semiconductor industry, and further develop the assembly, testing and packaging (ATP) capabilities for semiconductor modules to be used across a wide range of applications including telecommunications, high performance computing, automotive, aerospace & defence, computer networks, and generative AI, at IBM Canada’s plant in Bromont, Quebec. The agreements reflect a combined investment valued at approximately $187M CAD.

“Today’s announcement is a massive win for Canada and our dynamic tech sector. It will create high-paying jobs, invest in innovation, strengthen supply chains, and help make sure the most advanced technologies are Canadian-made. Semiconductors power the world, and we’re putting Canada at the forefront of that opportunity,” said the Right Honourable Justin Trudeau, Prime Minister of Canada
In addition to the advancement of packaging capabilities, IBM will be conducting R&D to develop methods for scalable manufacturing and other advanced assembly processes to support the packaging of different chip technologies, to further Canada’s role in the North American semiconductor supply chain and expand and anchor Canada’s capabilities in advanced packaging.
The agreements also allow for collaborations with small and medium-sized Canadian-based enterprises with the intent of fostering the development of a semiconductor ecosystem, now and into the future.
“IBM has long been a leader in semiconductor research and development, pioneering breakthroughs to meet tomorrow’s challenges. With the demand for compute surging in the age of AI, advanced packaging and chiplet technology is becoming critical for the acceleration of AI workloads,” said Darío Gil, IBM Senior Vice President and Director of Research. “As one of the largest chip assembly and testing facilities in North America, IBM’s Bromont facility will play a central role in this future. We are proud to be working with the governments of Canada and Quebec toward those goals and to build a stronger and more balanced semiconductor ecosystem in North America and beyond.”
IBM Canada’s Bromont plant is one of North America’s largest chip assembly and testing facilities, having operated in the region for 52 years. Today, the facility transforms advanced semiconductor components into state-of-the-art microelectronic solutions, playing a key role in IBM’s semiconductor R&D leadership alongside IBM’s facilities at the Albany NanoTech Complex and throughout New York’s Hudson Valley. These agreements will help to further establish a corridor of semiconductor innovation from New York to Bromont. 
“Advanced packaging is a crucial component of the semiconductor industry, and IBM Canada’s Bromont plant has led the world in this process for decades,” said Deb Pimentel, president of IBM Canada. “Building upon IBM’s 107-year legacy of technology innovation and R&D in Canada, the Canadian semiconductor industry will now become even stronger, allowing for robust supply chains and giving Canadians steady access to even more innovative technologies and products. This announcement represents just one more example of IBM’s leadership and commitment to the country’s technology and business landscape.”
Chip packaging, the process of connecting integrated circuits on a chip or circuit board, has become more complex as electronic devices have shrunk and the components of chips themselves get smaller and smaller. IBM announced the world’s first 2 nanometer chip technology in 2021 and, as the semiconductor industry moves towards new methods of chip construction, advances in packaging will grow in importance. 
“Semiconductors are part of our everyday life. They are in our phones, our cars, and our appliances. Through this investment, we are supporting Canadian innovators, creating good jobs, and solidifying Canada’s semiconductor industry to build a stronger economy. Canada is set to play a larger role in the global semiconductor industry thanks to projects like the one we are announcing today. Because, when we invest in semiconductor and quantum technologies, we invest in economic security.”  — The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry
“This investment by IBM in Bromont will ensure that Quebec continues to stand out in the field of microelectronics. An increase in production capacity will solidify Quebec’s position in the strategic microelectronics sector in North America.” — The Honourable Pierre Fitzgibbon, Minister of Economy, Innovation and Energy, Minister responsible for Regional Economic Development and Minister responsible for the Metropolis and the Montreal region
About IBMIBM is a leading provider of global hybrid cloud and AI, and consulting expertise. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. More than 4,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in semiconductors, AI, quantum computing, industry-specific cloud solutions and consulting deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service. Visit www.ibm.com for more information. 
Media ContactLorraine BaldwinIBM [email protected] 
Willa HahnIBM [email protected]
Photo – https://mma.prnewswire.com/media/2397908/IBM_Canada_employee_at_the_IBM_Bromont_plant_holding_a_wafer.jpg
Logo – https://mma.prnewswire.com/media/95470/ibm_logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/ibm-government-of-canada-government-of-quebec-sign-agreements-to-strengthen-canadas-semiconductor-industry-302128212.html

Continue Reading

Artificial Intelligence

HITACHI ACQUIRES MA MICRO AUTOMATION OF GERMANY IN EFFORT TO ACCELERATE GLOBAL EXPANSION OF ROBOTIC SI BUSINESS IN THE MEDICAL AND OTHER FIELDS

Published

on

hitachi-acquires-ma-micro-automation-of-germany-in-effort-to-accelerate-global-expansion-of-robotic-si-business-in-the-medical-and-other-fields

HOLLAND, Mich., April 26, 2024 /PRNewswire/ — Hitachi Ltd. (TSE: 6501, “Hitachi”) has signed a stock purchase agreement on April 26 to acquire all shares of MA micro automation GmbH (“MA micro automation”, headquartered in St. Leon-Rot, Germany) from MAX Management GmbH (a subsidiary of MAX Automation SE). MA micro automation is a leading provider of robotic and automation technology (robotic SI) including high-speed linear handling systems, high-precision assembly lines, and high-speed vision inspection technology for Europe, North America, and Southeast Asia, for EUR 71.5M million. The transaction is expected to close in the second half of 2024, pending completion of the customary regulatory filings. After the acquisition is completed, MA micro automation will join JR Automation Technologies, LLC (“JR Automation”), a market leader in providing advanced automation solutions and digital technologies in the robotic system integration business for North America, Europe, and Southeast Asia as a continued effort to expand the company’s global presence.

MA micro automation is a technology leader for automation solutions within micro-assembly. Through its state-of-the-art proprietary high-speed and high-precision automation know-how, combined with unique optical image inspection capabilities, MA micro automation serves high-growth med-tech automation end-markets, covering the production, assembly, and testing medical and optical components including contact lenses, IVD and diabetes diagnostics consumables, and injection molding for medical use. The company was established in 2003 through a carve-out from Siemens*1 and since 2013 has been part of the MAX Automation group. 
JR Automation is a leading provider of intelligent automated manufacturing technology solutions, serving customers across the globe in a variety of industries including automotive, life sciences, e-mobility, consumer and industrial products. With over 20 locations between North America, Europe, and Southeast Asia, the leading integrator offers nearly 2 million square feet (185,806 sq. m) of available build and engineering floorspace. This acquisition allows JR Automation to further grow and strengthen both the company’s geographical footprint and their continued commitment on expanding support capabilities within the European region and medical market vertical.
“MA micro automation provides engineering, build and support expertise with established capabilities in complex vision applications, high-speed and high-precision automation technologies. When integrated with JR Automation’s uniform global process and digital technologies, this partnership will further enhance our ability to deliver added value and support to all of our customers worldwide and continue to grow our capabilities in the medical market,” says Dave DeGraaf, CEO of JR Automation. “As we integrate this new dimension, impressive talents and abilities of the MA micro automation team we further enhance our ability to serve our customers, creating a more robust and globally balanced offering.”
With this acquisition, Hitachi aims to further enhance its ability to provide a “Total Seamless Solution*2” to connect manufacturer’s factory floors seamlessly and digitally with their front office data, allowing them to achieve total optimization and bringing Industry 4.0 to life. This “Total Seamless Solution” strategy links organizations’ operational activities such as engineering, supply chain, and purchasing to the plant floor and allows for real time, data-driven decision-making that improves the overall business value for customers.
Kazunobu Morita, Vice President and Executive Officer, CEO of Industrial Digital Business Unit, Hitachi, Ltd. says, “We are very pleased to welcome MA micro automation to the Hitachi Group. The team is based in Europe, providing robotic SI to global medical device manufacturing customers with its high technological capabilities and will join forces with JR Automation and Hitachi Automation to strengthen our global competitiveness. Hitachi aims to enhance its ability to provide value to customers and grow alongside them by leveraging its strengths in both OT, IT, including robotic SI, and “Total Seamless Solution” through Lumada*3’s customer co-creation framework.”
Joachim Hardt, CEO MA micro automation GmbH says, “Following the successful establishment and growth of MA micro automation within the attractive automation market for medical technology products, we are now opening a new chapter. Our partnership with Hitachi will not only strengthen our global competitive position, but we will also benefit from joint technological synergies and a global market presence.  We look forward to a synergistic partnership with Hitachi and JR Automation.”
Outline of MA micro automation    
Name
MA micro automation GmbH
Head Office
St. Leon-Rot, Germany
Representative
Joachim Hardt (CEO)
Outline of Business
Automation solutions within micro-assembly
Total no. of Employees:
Approx. 200 (As of April 2024)
Founded
2003
Revenues (2023)
€ 46.5 million
Website

Home


*1
“Siemens” is a registered trademark or trademark of Siemens Trademark GmbH & Co. KG in the U.S. and other countries.
*2
“Total Seamless Solution” is a registered trademark of Hitachi, Ltd. in the U.S. and Japan.
*3
Lumada: A collective term for solutions, services and technologies based on Hitachi’s advanced digital technologies for creating value from customers’ data accelerating digital innovation. https://www.hitachi.com/products/it/lumada/global/en/index.html
About JR AutomationEstablished in 1980, JR Automation is a leading provider of intelligent automated manufacturing technology solutions that solve customers’ key operational and productivity challenges. JR Automation serves customers across the globe in a variety of industries, including automotive, life sciences, aerospace, and more.  
In 2019, JR Automation was acquired by Hitachi, Ltd. In a strategic effort towards offering a seamless connection between the physical and cyber space for industrial manufacturers and distributers worldwide. With this partnership, JR Automation provides customers a unique, single-source solution for complete integration of their physical assets and data information, offering greater speed, flexibility, and efficiencies towards achieving their Industry 4.0 visions. JR Automation employs over 2,000 people at 21 manufacturing facilities in North America, Europe, and Asia.  For more information, please visit www.jrautomation.com.   
About Hitachi, Ltd.Hitachi drives Social Innovation Business, creating a sustainable society through the use of data and technology. We solve customers’ and society’s challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products. Hitachi operates under the 3 business sectors of “Digital Systems & Services” – supporting our customers’ digital transformation; “Green Energy & Mobility” – contributing to a decarbonized society through energy and railway systems, and “Connective Industries” – connecting products through digital technology to provide solutions in various industries. Driven by Digital, Green, and Innovation, we aim for growth through co-creation with our customers. The company’s revenues as 3 sectors for fiscal year 2023 (ended March 31, 2024) totaled 8,564.3 billion yen, with 573 consolidated subsidiaries and approximately 270,000 employees worldwide. For more information on Hitachi, please visit the company’s website at https://www.hitachi.com.
Photo – https://mma.prnewswire.com/media/2398552/CENTAURI_IVD_Platform.jpg Logo – https://mma.prnewswire.com/media/2392427/4673549/JR_Automation_and_Hitachi_Combined_Mark_full_color_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/hitachi-acquires-ma-micro-automation-of-germany-in-effort-to-accelerate-global-expansion-of-robotic-si-business-in-the-medical-and-other-fields-302128612.html

Continue Reading

Trending